Nxera Pharma Co.,Ltd. (520A.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenJPY 394.00

From 52W high−46.88%

Volume236500.00

Market capJPY 7.05B

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

JPY 394.00

From 52W high

−46.88%

Volume

236500.00

Market cap

JPY 7.05B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

53.9

MomentumView details →

1D Return

−3.21%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−3.21%

YTD Return

—

1Y Return

—

RSI (14)

53.9

vs 50D SMA

+24.26%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

J-Pharma announced a transition to an executive officer system to strengthen management and business execution, with Shinya Hirata newly appointed as executive officer in charge of clinical development and regulatory affairs.19d ago

The USFDA completed an inspection of Aurolife Pharma's Raleigh Plant in North Carolina, USA, from 24 March 2025 to 10 April 2025, issued a Form 483 with 11 observations, and subsequently closed the inspection with a Voluntary Action Indicated (VAI) classification.35d ago

Similar companies

Nano Holdings,Inc.4571.T Solasia Pharma K.K.4597.T Tsubota Laboratory Incorporated4890.T CellSource Co.,Ltd.4880.T BrightPath Biotherapeutics Co.,Ltd.4594.T Chiome Bioscience Inc.4583.T Find similar companies →

Latest newsMore news →

J-Pharma announced a transition to an executive officer system to strengthen management and business execution, with Shinya Hirata newly appointed as executive officer in charge of clinical development and regulatory affairs.19d ago The USFDA completed an inspection of Aurolife Pharma's Raleigh Plant in North Carolina, USA, from 24 March 2025 to 10 April 2025, issued a Form 483 with 11 observations, and subsequently closed the inspection with a Voluntary Action Indicated (VAI) classification.35d ago